Clinical Trials Directory

Trials / Unknown

UnknownNCT01233934

Comparative Study of Two Forms of Topical Dexchlorpheniramine Maleate (Cream Versus Gel) for Insect Bites

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Mantecorp Industria Quimica e Farmaceutica Ltd. · Industry
Sex
All
Age
2 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Insect bite related symptoms (pruritus and papules) are caused by the release of histamine by mast cells in the skin. Topical anti-histaminics can be used to promote relief of these symptoms. Dexchlorpheniramine maleate 1% cream is a topical anti-histaminic formulation approved by ANVISA in Brazil for the relief of skin irritation and allergies, including the ones caused by insect bites. The aim of the present study is to demonstrate non-inferiority of a new pharmacological preparation of dexchlorpheniramine maleate (1% gel) with the standard preparation (1% cream) for the relief of insect bite related symptoms and to demonstrate the safety of both preparations.

Conditions

Interventions

TypeNameDescription
DRUGDexchlorpheniramine 1% GelSmall amount applied over the lesion twice a day for 7 days.
DRUGDexchlorpheniramine 1% CreamSmall amount applied over the lesion twice a day for 7 days.

Timeline

Start date
2011-02-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-11-03
Last updated
2010-11-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01233934. Inclusion in this directory is not an endorsement.